Name | Description | Official Website | Industry | Launch Date | Product Parent Company | ||
---|---|---|---|---|---|---|---|
An antiviral drug candidate also known as GS-5734 developed by Gilead Sciences to treat Ebola virus that shows potential to treat coronavirus 2019-nCoV. | |||||||
ambrisentan | |||||||
brexucabtagene autoleucel | |||||||
remdesivir | |||||||
aztreonam for inhalation solution | |||||||
axicabtagene ciloleucel | |||||||
medicine | |||||||
oseltamivir | |||||||
adefovir dipivoxil | |||||||
amphotericin B | |||||||
sofosbuvir/velpatasvir | |||||||
sacituzumab govitecan-hziy | |||||||
medicine | |||||||
Medication | |||||||
medicine | |||||||
ranolazine |